| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/11/2007 | CN1943640A The application of Shaoshiduogan composition in preparations of the medicines for preventing and curing rheumatoid arthritis |
| 04/11/2007 | CN1943635A Chinese traditional medicinal preparation for treating bone injuries and osteonosus |
| 04/11/2007 | CN1943628A Double sticking double effect plaster by internal and external combined treatment |
| 04/11/2007 | CN1943610A Chinese medicine preparation for traumatic injury and blood stasis and swelling pain |
| 04/11/2007 | CN1943574A Method for preparing tinidazole dispersion tablet and use |
| 04/11/2007 | CN1309830C Variants of TRAF2 which act as an inhibitor of TNF-alpha signaling pathway |
| 04/11/2007 | CN1309737C Recombinant gelatins |
| 04/11/2007 | CN1309717C 4-aryl group-5H-thoifuran-2-ketone derivative, producing method and use thereof |
| 04/11/2007 | CN1309711C 3-amido-1,2-benzoisoxazole derivatives, process for preparation, and use thereof |
| 04/11/2007 | CN1309710C Pyrimidine derivitive |
| 04/11/2007 | CN1309704C Anthranyl amides and their use as medicaments |
| 04/11/2007 | CN1309419C A Blocking monoclonal antibody to VLA-1 and its use |
| 04/11/2007 | CN1309406C Medicinal preparation for treating rheumatism and rheumatoid diseases |
| 04/11/2007 | CN1309403C Medicinal wine having therapeutic functions for scapulohumeral periarthritis, arthritis and pains of arms and legs |
| 04/11/2007 | CN1309394C Rue extract preparing method |
| 04/11/2007 | CN1309388C Treatment of inflammatory disorders |
| 04/11/2007 | CN1309380C Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 04/11/2007 | CN1309310C Method for increasing pet activity |
| 04/10/2007 | US7202343 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 04/10/2007 | US7202331 For inducing immune response and administering immunotherapy |
| 04/10/2007 | US7202278 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; for treatment of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases |
| 04/10/2007 | US7202277 Benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 04/10/2007 | US7202274 Cyclic hemiacetal derivative and use thereof |
| 04/10/2007 | US7202273 Prevention of menopausal syndrome |
| 04/10/2007 | US7202268 1-Substituted with an alkylthioalkyl-, alkylsulfonylalkyl- or alkylaminosulfonylalkyl- group, e.g., 7-chloro-2-methyl-1-{3-[(methylsulfonyl)amino]-propyl}-N-[(1S)-endo-(1,3,3-trimethylbicyclo-[2.2.1]hept-2-yl)-1H-indole-3-carboxamide; cannabinoid CB2 receptor agonists |
| 04/10/2007 | US7202263 [2-(Benzodioxo-5-ylalkylamino)ethoxy]-imidazol-1-yl-benzene derivatives, e.g., N-[2-(4-(imidazol-1-yl)phenoxy)ethyl]-N-[(1,3-benzodioxol-5-yl)methyl]amine; treating congestive heart failure |
| 04/10/2007 | US7202250 2-substituted, especially 2-amino-substituted, e.g., [N-(1-ethyl)propyl]-5-(2,4-dimethoxyphenyl)-3,6-dimethylpyrazine-2-amine; bind with high affinity and high selectivity to CRF1 receptors and are used to treat central nervous system disorders |
| 04/10/2007 | US7202249 Antagonists of chemokine receptors |
| 04/10/2007 | US7202248 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 04/10/2007 | US7202247 Such as 4-(3-(2,4-dimethoxy-5-thiophen-2-yl-phenyl)-propynoyl)-benzoic acid methyl ester; for inhibiting expression of vascular cellular adhesion molecules |
| 04/10/2007 | US7202238 Diazabicyclo alkane derivatives with NK1 antagonistic activity |
| 04/10/2007 | US7202210 Premature peptide for use in treatment of nervous system, muscular, heart, diabetic and bone disorders |
| 04/10/2007 | CA2407100C 1-aroyl-piperidinyl benzamidines |
| 04/10/2007 | CA2401194C Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material |
| 04/10/2007 | CA2337991C Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents |
| 04/10/2007 | CA2307068C Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2007 | CA2227977C Use in a composition of an extract of at least one labiate |
| 04/10/2007 | CA2171289C Il8 inhibitors |
| 04/10/2007 | CA2148194C Cyclopeptides of the formula i |
| 04/10/2007 | CA2102447C Cyclopeptides |
| 04/05/2007 | WO2007037667A1 Pharmaceutical form for the treatment of patients with acute cases and exacerbations of rheumatoid arthritis and related acute disorders |
| 04/05/2007 | WO2007037666A1 Pharmaceutical form containing methocarbamol, meloxicam and betamethasone |
| 04/05/2007 | WO2007037554A1 Adsorbent for advanced glycation endproducts |
| 04/05/2007 | WO2007037297A1 Composition effective for prevention and treatment of adult disease |
| 04/05/2007 | WO2007036688A1 Pharmaceutically acceptable salts and hydrates of risedronic acid |
| 04/05/2007 | WO2007036016A1 Therapeutic molecules and their uses |
| 04/05/2007 | WO2006136859A3 Indoli zine derivatives and their use as crth2 antagonists |
| 04/05/2007 | WO2006133286A3 Treatment of tnf antagonist-resistant inflammatory disorders and related methods |
| 04/05/2007 | WO2006117600A3 Double-stranded synthetic oligonucleotides useful for inducing apoptosis of osteoclasts for the treatment of osteopenic pathologies |
| 04/05/2007 | US20070078104 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; antiinflammatory agents |
| 04/05/2007 | US20070077627 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 04/05/2007 | US20070077597 Method for identifying modulators of G protein coupled receptor signaling |
| 04/05/2007 | US20070077232 Conditioned cell culture medium compositions and methods of use |
| 04/05/2007 | DE60124600T2 Zusammensetzungen und Verfahren zur Behandlung von Zuständen, die auf Östrogen ansprechen Compositions and methods for treating conditions responsive to estrogen |
| 04/05/2007 | DE112004002847T5 Verwendung von Blutplättchen oder blutblättchenreichem Plasma (PRP) Use of platelets or blood platelet-rich plasma (PRP) |
| 04/05/2007 | CA2624686A1 Therapeutic molecules and their uses |
| 04/05/2007 | CA2623533A1 Pharmaceutically acceptable salts and hydrates of risedronic acid |
| 04/04/2007 | EP1770161A2 BMP-11 compositions |
| 04/04/2007 | EP1770083A1 Inorganic ion receptor-active compounds |
| 04/04/2007 | EP1769804A2 Method of increasing bone toughness and stiffness and reducing fractures |
| 04/04/2007 | EP1769800A2 Estrogen replacement therapy |
| 04/04/2007 | EP1768965A1 Method for preparing 5-¬4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3h-¬1,2,4|-triazin-2-yl|benzamide derivatives with p2x7 inhibiting activity by reaction of the derivative unsubstituted in 4-position of the triazine with an oxiran in the presence of a lewis acid |
| 04/04/2007 | EP1768748A2 Compositions comprising strontium and vitamin d and uses thereof |
| 04/04/2007 | EP1536797B1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough |
| 04/04/2007 | EP1532135B1 Nf-kb inhibitors |
| 04/04/2007 | EP1414858B1 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses |
| 04/04/2007 | EP1383501B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/04/2007 | EP1362033B1 Pyridine matrix metalloproteinase inhibitors |
| 04/04/2007 | EP1331932B1 Use of xestospongin c for treating or preventing hiv infection |
| 04/04/2007 | EP1259595B1 Integrin antagonists |
| 04/04/2007 | CN1942581A Antibody with osteoclast-related protein as target |
| 04/04/2007 | CN1940068A Novel receptor nucleic acids and polypeptides |
| 04/04/2007 | CN1939905A Indole acrylic acid derivative and its use for preparing immune inhibitor |
| 04/04/2007 | CN1939895A Compound, composition and method for preventing from neurodegeneration in injury of central nervous system |
| 04/04/2007 | CN1939541A Immunostimulatory nucleic acids |
| 04/04/2007 | CN1939521A Medicine for treating gout |
| 04/04/2007 | CN1939510A Animal's medicinal preparation with heat-clearing, blood-cooling, emmenagogic and bone-connecting functions and its making method |
| 04/04/2007 | CN1939500A Kidney-tonifying and bone-strengthening capsules and preparation thereof |
| 04/04/2007 | CN1939493A Chinese-medicinal preparation for treating cervical vertebrae, vertebrae lumbale, rheumatosis and rheumatoid disease |
| 04/04/2007 | CN1939492A Chinese medicine for treating cervical spondylosis |
| 04/04/2007 | CN1939491A Chinese medicinal herbs for treating spur and its preparation |
| 04/04/2007 | CN1939489A Ointment for treating arthralgia-syndrome and analgesia |
| 04/04/2007 | CN1939480A Chinese-medicinal compound preparation for treating injury |
| 04/04/2007 | CN1939446A Externally-applied Chinese-medicinal composition for treating lumbago and skelalgia |
| 04/04/2007 | CN1939427A Prickly polygonum extract, its preparation, medicinal composition and use |
| 04/04/2007 | CN1939394A Use of Chinese patent drug Yupingfeng preparation with milkvetch root, largehead atractylodes rhizome and divaricate saposhnikovia root in treatment of osteoporosis |
| 04/04/2007 | CN1939386A Medicated liquor for treating wound |
| 04/04/2007 | CN1939385A Medicated liquor for treating wound |
| 04/04/2007 | CN1939373A Chinese-medicine injection preparation and its making method |
| 04/04/2007 | CN1939353A Medicated liquor for treating functional uterus hemorrhage |
| 04/04/2007 | CN1939351A Method for inspecting lucid ganoderma product quality |
| 04/04/2007 | CN1939343A Bone-peptide sodium chloride injection and its making method |
| 04/04/2007 | CN1939342A Injection bone peptide freeze-drying preparation and its making method |
| 04/04/2007 | CN1939332A Medical usage of S-adenyhomotype cysteine |
| 04/04/2007 | CN1939314A Ibandronic acid for the treatment and prevention of osteoporosis |
| 04/04/2007 | CN1308329C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 04/04/2007 | CN1308320C Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 04/04/2007 | CN1308310C Nitrogenous aromatic ring compounds |
| 04/04/2007 | CN1308030C Pharmaceutical composition containing effective part of 'Ruyi Jinhuang Powder' and preparation method thereof |
| 04/04/2007 | CN1308026C Externally applied medicated wine for relaxing muscles and joints and dispelling wind and wetness evils |